Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT04573933
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18 years old
* High grade serous or clear cell ovarian cancer or endometrioid, including primary peritoneal cancer and fallopian tubes
* Treatment with PARP inhibitor (OLAPARIB, NIRAPARIB) in maintenance after sensitive platinum relapse
* No objection made
Exclusion Criteria:
* \- Patients under judicial protection (guardianship)
* Refusal to participate
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04573933
Study Brief:
Protocol Section:
NCT04573933